July 2024: A new study, published on July 3, 2024, indicates patients taking semaglutide such as Wegovy may face an increased risk of serious eye injuries, including nonarteritic anterior ischemic optic neuropathy (NAION)
Its time to stop the guessing games with your medication
Overall architecture In the cryo-EM structure of the GLP-2GLP-2RG s complex, most of the receptor core, G protein subunits and the first 31 amino acids of GLP-2 were observed with high-resolution features, thereby allowing for accurate modeling of side-chain rotamers (Fig
GLP-1s and Pregnancy Weight loss injections should not be taken when pregnant, or when trying to conceive
The finding that GLP-1(936) acts by reducing the number of docked granules provides a simple and unifying explanation for its capacity to inhibit glucagon secretion regardless of whether it is evoked by low glucose, membrane depolarisation or a -adrenergic agonist
Glucagon-Like Peptide 1 Receptor Agonists and Coronary Events Composite Outcomes Including Coronary Events Coronary events form a part of cardiovascular composite outcomes, such as cardiovascular mortality and major adverse cardiovascular events (MACE)
